Achieving COVID-19 vaccine equity by making comorbidities redundant for those above 45 years
By following the U.K. model of vaccinating people based on age bands rather than focussing on comorbidities, millions of people
Read More
Month: March 2021
Should Covaxin trial continue till 130 cases are recorded?
According to details posted on the clinical trial registry, the company had planned to “continue the phase-3 trial until 130
Read More
Will adenovirus antibodies reduce the efficacy of COVID-19 vector vaccines?
While it is unclear if pre-existing antibodies to adenovirus vector will affect vaccine efficacy, it is possible that repeated vaccination using adenovirus-based vaccine either as a booster or as annual vaccination, if the need arises, will result in reduced efficacy due to vector immunity.
Read More
As COVID-19 cases spike in a few States, what is causing a decline in Kerala?
Even as recently as March 6, March 4, March 3, March 2 and March 1 the Health Ministry mischievously implicated
Read More
Covaxin should no longer be available in ‘clinical trial mode’
The vaccine efficacy was measured based on symptomatic COVID-19 disease — mild, moderate or severe — two weeks after the
Read More
IGIB: In vaccinated people, Covishield first dose is highly immunogenic if already infected
The results have been posted on medRxiv preprint server. Preprints are yet to be peer-reviewed and published in scientific journals.
Read More
Doctors say comorbidities list for COVID-19 vaccination is highly restrictive
“The list of comorbidities provided by the Health Ministry is overly restrictive and complicated. Many conditions, including obesity, have been
Read More